An exploratory study for clinical benefits of the guideline on drug use in subjects with pediatric obsessive compulsive disorder.

Trial Profile

An exploratory study for clinical benefits of the guideline on drug use in subjects with pediatric obsessive compulsive disorder.

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 14 May 2016

At a glance

  • Drugs Fluvoxamine (Primary) ; Paroxetine (Primary)
  • Indications Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top